Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
2023 · New England Journal of Medicine · 220 citations
https://doi.org/10.1056/nejmoa2210140
L
Lara E. Davis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
234
Papers
7.2K
Citations
29
h-index
65
i10-index
Lara E. Davis is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Computational Drug Discovery Methods. The author has an h-index of 29, co-authored 199 publications.
ORCID: 0000-0002-6480-1611Papers by this author
worksPseudoprogression of CNS metastatic disease of alveolar soft part sarcoma during anti-PDL1 treatment
2018 · Radiology Case Reports · 16 citations
https://doi.org/10.1016/j.radcr.2018.05.013
Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study
2024 · Research Square · 1 citations
https://doi.org/10.21203/rs.3.rs-5397300/v1
Additional file 31: of Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8288402
Additional file 23: of Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8288372
Additional file 21: of Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8288366
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat